Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox B5 (HOXB5) mRNA is the transcript of a gene belonging to the Antp homeobox family, encoding a transcription factor that serves as a master regulator of positional identity and organogenesis during embryonic development. It plays a vital role in the formation of the lungs, gut, and enteric nervous system, and in adults, it is a key marker and regulator of long-term hematopoietic stem cell self-renewal. In many human cancers, HOXB5 mRNA is significantly upregulated, acting as an oncogenic driver that promotes cell proliferation, invasion, and the epithelial-mesenchymal transition (EMT). Because the HOXB5 protein is a transcription factor and traditionally difficult to target with small molecules, the mRNA itself is the primary focus for therapeutic intervention using RNA-silencing technologies like siRNA and ASOs. High levels of HOXB5 mRNA are often correlated with poor clinical outcomes and resistance to standard treatments, making it both a promising therapeutic target and a valuable prognostic biomarker.
RNA interference (siRNA-mediated cleavage), RNase H-mediated degradation (ASO-mediated), Translation inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox B5 mRNA (HOXB5 mRNA).